Is Rituximab a Wonder-drug? Dr Diana Conrad, Director of the Uveitis Service at the Royal Women’s and Children’s Hospital (the only speciality uveitis service in Queensland) explores a review paper on the use of rituximab for the treatment of non-infectious uveitis and scleritis. Dr Conrad notes an impressive response rate to rituximab for patients where first and second-line treatments have failed. Given the success of rituximab, and the biosimilars entering the market, Dr Conrad includes some important messages for ophthalmologists using the drug.  View article here